Varun Chaudhary

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 45

Top Topics

Randomized Controlled Trial

Systematic Review

Vascular Endothelial Growth Factor

Optical Coherence Tomography

Top Venues

Eye (London, England)

Journal of vitreoretinal diseases

Acta ophthalmologica

Ophthalmology and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Keean Nanji, Jim Xie, Amin Hatamnejad, Daiana R Pur, Mark Phillips, Dena Zeraatkar, Tien-Yin Wong, Robyn H Guymer, Peter K Kaiser, Sobha Sivaprasad, Mohit Bhandari, David H Steel, Charles C Wykoff, Varun Chaudhary
Exploring the fragility of meta-analyses in ophthalmology: a systematic review. Eye (London, England) (2024)
Jessica A Cao, Hasenin Al-Khersan, Varun Chaudhary, Charles C Wykoff
Retinal non-perfusion: recognizing and defining what is important. Eye (London, England) 38 (9) (2024)
Dena Zeraatkar, Tyler Pitre, Mark R Phillips, David H W Steel, Charles C Wykoff, Tien-Yin Wong, Mohit Bhandari, Varun Chaudhary, null null
The ophthalmologist's guide to evaluating the certainty of evidence using the GRADE approach. Eye (London, England) 38 (9) (2024)
Dena Zeraatkar, Tyler Pitre, Mark R Phillips, David H W Steel, Charles C Wykoff, Tien-Yin Wong, Mohit Bhandari, Varun Chaudhary, null null
The ophthalmologist's guide to evaluating the certainty of evidence using the GRADE approach. Eye (London, England) 38 (9) (2024)
Jessica A Cao, Hasenin Al-Khersan, Varun Chaudhary, Charles C Wykoff
Retinal non-perfusion: recognizing and defining what is important. Eye (London, England) 38 (9) (2024)
Dena Zeraatkar, Tyler Pitre, Mark R Phillips, David H W Steel, Charles C Wykoff, Tien-Yin Wong, Mohit Bhandari, Varun Chaudhary, null null
The ophthalmologist's guide to evaluating the certainty of evidence using the GRADE approach. Eye (London, England) 38 (9) (2024)
Jessica A Cao, Hasenin Al-Khersan, Varun Chaudhary, Charles C Wykoff
Retinal non-perfusion: recognizing and defining what is important. Eye (London, England) 38 (9) (2024)
Jessica A Cao, Hasenin Al-Khersan, Varun Chaudhary, Charles C Wykoff
Retinal non-perfusion: recognizing and defining what is important. Eye (London, England) 38 (9) (2024)
Jessica A Cao, Hasenin Al-Khersan, Varun Chaudhary, Charles C Wykoff
Retinal non-perfusion: recognizing and defining what is important. Eye (London, England) 38 (9) (2024)
Raziyeh Mahmoudzadeh, Mirataollah Salabati, Rachel Israilevich, John W Hinkle, Anthony Obeid, M Ali Khan, Jason Hsu, Varun Chaudhary, Sunir J Garg
Outcomes of Eyes Lost to Follow-up After Treatment With Intraocular or Periocular Steroid Injections. Journal of vitreoretinal diseases 8 (2) (2024)
Dena Zeraatkar, Tyler Pitre, Mark R Phillips, David H W Steel, Charles C Wykoff, Tien-Yin Wong, Mohit Bhandari, Varun Chaudhary, null null
The ophthalmologist's guide to evaluating the certainty of evidence using the GRADE approach. Eye (London, England) 38 (9) (2024)
Jessica A Cao, Hasenin Al-Khersan, Varun Chaudhary, Charles C Wykoff
Correction: Retinal non-perfusion: recognizing and defining what is important. Eye (London, England) (2024)
Dena Zeraatkar, Tyler Pitre, Mark R Phillips, David H W Steel, Charles C Wykoff, Tien-Yin Wong, Mohit Bhandari, Varun Chaudhary, null null
The ophthalmologist's guide to evaluating the certainty of evidence using the GRADE approach. Eye (London, England) (2024)
Jessica A Cao, Hasenin Al-Khersan, Varun Chaudhary, Charles C Wykoff
Retinal non-perfusion: recognizing and defining what is important. Eye (London, England) (2024)
Dena Zeraatkar, Tyler Pitre, Mark R Phillips, David H W Steel, Charles C Wykoff, Tien-Yin Wong, Mohit Bhandari, Varun Chaudhary, null null
The ophthalmologist's guide to evaluating the certainty of evidence using the GRADE approach. Eye (London, England) (2024)
Raziyeh Mahmoudzadeh, Mirataollah Salabati, Rachel Israilevich, John W Hinkle, Anthony Obeid, M Ali Khan, Jason Hsu, Varun Chaudhary, Sunir J Garg
Outcomes of Eyes Lost to Follow-up After Treatment With Intraocular or Periocular Steroid Injections. Journal of vitreoretinal diseases 8 (2) (2024)
Jessica A Cao, Hasenin Al-Khersan, Varun Chaudhary, Charles C Wykoff
Retinal non-perfusion: recognizing and defining what is important. Eye (London, England) (2024)
Yaping Chang, Mark R Phillips, Robyn H Guymer, Lehana Thabane, Mohit Bhandari, Varun Chaudhary, null null
Correction: The 5 min meta-analysis: understanding how to read and interpret a forest plot. Eye (London, England) (2023)
Anna Kabanovski, Bindra Shah, Chelsea D'Silva, Julia Ma, Simona C Minotti, Jenny Qian, Wendy Hatch, Robert Reid, Varun Chaudhary, Sherif El-Defrawy, Iqbal Ike Ahmed, Matthew B Schlenker
Multi-center validation of Catquest-9SF visual function questionnaire in Ontario, Canada. PloS one 18 (7) (2023)
Keean Nanji, Gurkaran S Sarohia, Jim S Xie, Nikhil S Patil, Mark Phillips, Dena Zeraatkar, Lehana Thabane, Robyn H Guymer, Peter K Kaiser, Sobha Sivaprasad, Srinivas R Sadda, Charles C Wykoff, Varun Chaudhary
Anti-vascular endothelial growth factor therapy and retinal non-perfusion in diabetic retinopathy: A meta-analysis of randomised trials. Acta ophthalmologica (2023)
Yaping Chang, Li Wang, Mark R Phillips, Charles C Wykoff, Sunir J Garg, Lehana Thabane, Mohit Bhandari, Varun Chaudhary, null null
What makes a good survey? Eye (London, England) (2023)
Kevin Kim, Dena Zeraatkar, Tyler S Pitre, Mark R Phillips, Charles C Wykoff, Sunir J Garg, Robyn H Guymer, Lehana Thabane, Mohit Bhandari, Varun Chaudhary, null null
Noninferiority randomised trials in ophthalmology. Eye (London, England) (2023)
Andrea J Darzi, Jason W Busse, Mark R Phillips, Charles C Wykoff, Robyn H Guymer, Lehana Thabane, Mohit Bhandari, Varun Chaudhary, null null
Interpreting results from randomized controlled trials: What measures to focus on in clinical practice. Eye (London, England) (2023)
Varun Chaudhary, null null
The need for a pragmatic, individualized treat-and-extend (T&E) treatment paradigm for centre-involving diabetic macular oedema. Eye (London, England) (2023)
Mark R Phillips, Charles C Wykoff, Lehana Thabane, Mohit Bhandari, Varun Chaudhary, null null
Correction to: The clinician's guide to p values, confidence intervals, and magnitude of effects. Eye (London, England) (2022)
Forough Farrokhyar, Philip Skorzewski, Mark R Phillips, Sunir J Garg, David Sarraf, Lehana Thabane, Mohit Bhandari, Varun Chaudhary, null null
When to believe a subgroup analysis: revisiting the 11 criteria. Eye (London, England) 36 (11) (2022)
Mark R Phillips, Varun Chaudhary
Measuring atrophy in age-related macular degeneration: why does reliability matter? Eye (London, England) 36 (8) (2022)
Mark R Phillips, Peter K Kaiser, Lehana Thabane, Mohit Bhandari, Varun Chaudhary, null null
Correction to: Risk of bias: why measure it, and how? Eye (London, England) (2022)
Anila Qasim, Tahira Devji, Mark R Phillips, Charles C Wykoff, Peter K Kaiser, Lehana Thabane, Mohit Bhandari, Varun Chaudhary, null null
Seeing the patient's perspective: a guide to patient-reported outcome measures and minimal important differences in ophthalmic research. Eye (London, England) 36 (7) (2022)
Daniel Rosenberg, Deven M Deonarain, Jonah Gould, Amirthan Sothivannan, Mark R Phillips, Gurkaran S Sarohia, Sobha Sivaprasad, Charles C Wykoff, Gemmy Cheung Chui Ming, David Sarraf, Sophie J Bakri, Varun Chaudhary
Efficacy, safety, and treatment burden of treat-and-extend versus alternative anti-VEGF regimens for nAMD: a systematic review and meta-analysis. Eye (London, England) (2022)
Varun Chaudhary, Gurkaran S Sarohia, Mark R Phillips, Daniel Park, Jim Xie, Dena Zeraatkar, Matthew Fung, Lehana Thabane, Anat Loewenstein, Frank G Holz, Sunir J Garg, Peter K Kaiser, Mohit Bhandari, Robyn H Guymer, Samantha Fraser-Bell, Sobha Sivaprasad, Charles C Wykoff
Role of anti-vascular endothelial growth factor in the management of non-proliferative diabetic retinopathy without centre-involving diabetic macular oedema: a meta-analysis of trials. Eye (London, England) (2022)
Jim S Xie, Keean Nanji, Mohammad Khan, Muhammad F Khalid, Sunir J Garg, Lehana Thabane, Sobha Sivaprasad, Varun Chaudhary
Publication trends in telemedicine research originating from Canada. Healthcare management forum 35 (3) (2022)
Varun Chaudhary, null null
Treat & extend in neovascular age-related macular degeneration: how we got here and where do we go next? Eye (London, England) (2022)
Alex Thabane, Mark R Phillips, Tien Y Wong, Lehana Thabane, Mohit Bhandari, Varun Chaudhary, null null
The clinician's guide to randomized trials: interpretation. Eye (London, England) 36 (3) (2022)
Sameer Parpia, Tim P Morris, Mark R Phillips, Charles C Wykoff, David H W Steel, Lehana Thabane, Mohit Bhandari, Varun Chaudhary, null null
Sensitivity analysis in clinical trials: three criteria for a valid sensitivity analysis. Eye (London, England) 36 (11) (2022)
Mark R Phillips, David H Steel, Charles C Wykoff, Jason W Busse, Raveendhara R Bannuru, Lehana Thabane, Mohit Bhandari, Varun Chaudhary, null null
A clinician's guide to network meta-analysis. Eye (London, England) 36 (8) (2022)
Sofia Bzovsky, Mark R Phillips, Robyn H Guymer, Charles C Wykoff, Lehana Thabane, Mohit Bhandari, Varun Chaudhary, null null
The clinician's guide to interpreting a regression analysis. Eye (London, England) 36 (9) (2022)
Varun Chaudhary, Frank G Holz, Sebastian Wolf, Edoardo Midena, Eric H Souied, Helmut Allmeier, George Lambrou, Tobias Machewitz, Paul Mitchell, null null
Association Between Visual Acuity and Fluid Compartments with Treat-and-Extend Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration: An ARIES Post Hoc Analysis. Ophthalmology and therapy 11 (3) (2022)
Maitri Pancholy, Philip P Storey, Edward H Wood, Varun Chaudhary, Anthony Obeid, Elizabeth Marlow, Nathan D Farley, Jeremy D Wolfe, Sunir J Garg
Incidence and Visual Outcomes of Endophthalmitis After Intravitreal Injection of Dexamethasone Implant vs Ranibizumab. Journal of vitreoretinal diseases 6 (5) (2022)
Anna Miroshnychenko, Dena Zeraatkar, Mark R Phillips, Sophie J Bakri, Lehana Thabane, Mohit Bhandari, Varun Chaudhary, null null
Cohort studies investigating the effects of exposures: key principles that impact the credibility of the results. Eye (London, England) 36 (5) (2022)
Yaping Chang, Mark R Phillips, Robyn H Guymer, Lehana Thabane, Mohit Bhandari, Varun Chaudhary, null null
The 5 min meta-analysis: understanding how to read and interpret a forest plot. Eye (London, England) 36 (4) (2022)
Andrea J Darzi, Jason W Busse, Mark R Phillips, Rishi P Singh, Frank G Holz, Lehana Thabane, Mohit Bhandari, Varun Chaudhary, null null
Guidelines for patient management: considerations before adoption into practice. Eye (London, England) 36 (6) (2022)
Mark R Phillips, Charles C Wykoff, Lehana Thabane, Mohit Bhandari, Varun Chaudhary, null null
The clinician's guide to p values, confidence intervals, and magnitude of effects. Eye (London, England) (2021)
Mark R Phillips, Peter K Kaiser, Lehana Thabane, Mohit Bhandari, Varun Chaudhary, null null
Risk of bias: why measure it, and how? Eye (London, England) (2021)
Keean Nanji, Mohammad Khan, Muhammad F Khalid, Jim S Xie, Gurkaran S Sarohia, Mark Phillips, Lehana Thabane, Sunir J Garg, Peter Kaiser, Sobha Sivaprasad, Charles C Wykoff, Varun Chaudhary
Treat-and-extend regimens of anti-vascular endothelial growth factor therapy for retinal vein occlusions: a systematic review and meta-analysis. Acta ophthalmologica (2021)